Lv1
20 积分 2023-04-04 加入
Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy
1天前
待确认
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
15天前
已完结
Humanization of T cell–mediated immunity in mice
21天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1个月前
已关闭
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD
1个月前
已完结
Transmembrane domain–driven PD-1 dimers mediate T cell inhibition
1个月前
已完结
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
1个月前
已完结
Application of CAR‐T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment
4个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
5个月前
已关闭
皖公网安备34019202002308
